Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Ovarian Hyperstimulation Syndrome in GnRH Agonist IVF Cycles: Randomized Study Comparing Hydroxyethyl Starch Versus Cabergoline and Hydroxyethyl Starch

NCT01530490 is registered in ClinicalTrials.gov with Hospital de Cruces as lead sponsor.

NCT NCT01530490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01530490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Ovarian Hyperstimulation Syndrome in GnRH Agonist IVF Cycles: Randomized Study Comparing Hydroxyethyl Starch Versus Cabergoline and Hydroxyethyl Starch
Lead sponsor
Hospital de Cruces
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2007
Completion date
September 30, 2010
Enrollment
80 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

complications associated with artificial fertilization, disorder of endocrine ovary